Skip to main content

Market Overview

AngioDynamics: Q4 Earnings Insights


Shares of AngioDynamics (NASDAQ:ANGO) were unchanged after the company reported Q4 results.

Quarterly Results

Earnings per share fell 124.00% over the past year to ($0.06), which were in line with the estimate of ($0.06).

Revenue of $58,332,000 declined by 39.43% year over year, which missed the estimate of $64,300,000.


Earnings guidance hasn't been issued by the company for now.

AngioDynamics hasn't issued any revenue guidance for the time being.

Details Of The Call

Date: Jul 16, 2020

Time: 08:00 AM

ET Webcast URL:

Recent Stock Performance

Company's 52-week high was at $21.90

Company's 52-week low was at $7.48

Price action over last quarter: Up 7.39%

Company Profile

AngioDynamics Inc designs, manufactures and sells medical, surgical and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings.


Related Articles (ANGO)

View Comments and Join the Discussion!

Posted-In: Earnings News

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at